Biomedical Engineering Reference
In-Depth Information
[86] Sanghvi P, Banakar UV. Ultrasonics: principles and biomedical applications. BioPharm
Int 1991;4:32-40.
[87] Machluf M, Kost J. Ultrasonically enhanced transdermal drug delivery experimental
approaches to elucidate the mechanism. J Biomater Sci Polym Ed 1993;5:147-56.
[88] Kendall M, Mitchell T, Wrighton-Smith P. Intradermal ballistic delivery of microparti-
cles into excised human skin for pharmaceutical applications. J Appl Biomater Biomech
2004;37:1733-41.
[89] Le L, Kost J, Mitragotri S. Combined effect of low-frequency ultrasound and iontopho-
resis: applications for transdermal heparin delivery. Pharm Res 2000;17:1151-4.
[90] Tokumoto S, Higo N, Sugibayashi K. Effect of electroporation and pH on the iontopho-
retic transdermal delivery of human insulin. Int J Pharm 2006;326:13-19.
[91] Murthy SN, Zhao YL, Hui SW, Sen A. Synergistic effect of anionic lipid enhancer and
electroosmosis for transcutaneous delivery of insulin. Int J Pharm 2006;326:1-6.
[92] Pillai O, Panchagnula R. Transdermal delivery of insulin from poloxamer gel:
ex vivo
and
in vivo
skin permeation studies in rat using iontophoresis and chemical enhancers.
J Control Release 2003;89:127-40.
[93] Lin W, Cormier M, Samiee A, Griffin A, Johnson B, Teng CL, et al. Transdermal deliv-
ery of antisense oligonucleotides with microprojection patches (Macroflux) technology.
Pharm Res 2001;18:1789-93.
[94] Jaskari T, Vuorio M, Kontturi K, Urtti A, Manzanares JA, Hirvonen J. Controlled trans-
dermal iontophoresis by ion-exchange fiber. J Control Release 2000;67:179-90.
[95] Jaskari T, Vuorio M, Kontturi K, Manzanares JA, Hirvonen J. Ion-exchange fibers and
drugs: an equilibrium study. J Control Release 2001;70:219-29.
[96] Hanninen K, Kaukonen AM, Kankkunen T, Hirvonen J. Rate and extent of ion-
exchange process: the effect of physico-chemical characteristics of salicylate anions.
J Control Release 2003;91:449-63.
[97] Vuorio M, Manzanares JA, Murtomaki L, Hirvonen J, Kankkunen T, Kontturi K. Ion-
exchange fibers and drugs: a transient study. J Control Release 2003;91:439-48.
[98] Kankkunen T, Huupponen I, Lahtinen K, Sundell M, Ekman K, Kontturi K, et al.
Improved stability and release control of levodopa and metaraminol using ion-exchange
fibers and transdermal iontophoresis. Eur J Pharm Sci 2002;16:273-80.
[99] Kankkunen T, Sulkava R, Vuorio M, Kontturi K, Hirvonen J. Transdermal iontophoresis
of tacrine
in vivo
. Pharm Res 2002;19:704-7.
[100] Lira LM, Córdoba de Torresi SI. Conducting polymer-hydrogel composites for electro-
chemical release devices: synthesis and characterization of semi-interpenetrating poly-
aniline-polyacrylamide networks. Electrochem Commun 2005;7:717-23.
[101] Conaghey OM, Corish J, Corrigan OI. Iontophoretically assisted
in vitro
membrane transport
of nicotine from a hydrogel containing ion exchange resins. Int J Pharm 1998;170:225-37.
[102] Ghosh TK, Banga AK. Methods of enhancement of transdermal drug delivery: part I,
physical and biochemical approaches. Pharm Technol 1993;17:72-98.
[103] Moss J, Bundgaard H. Prodrugs of peptides. 7. Transdermal delivery of thyrotropin-
releasing hormone (TRH) via prodrugs. Int J Pharm 1990;66:39-45.
[104] Kahn M. Peptide secondary structure mimetics: recent advantages and future chal-
lenges. Synlett 1993;11:821-6.
[105] Hruby VJ. Conformational and topographical considerations in the design of biologi-
cally active peptide ligands. Biopolymers 1993;33:1073-82.
[106] Luthman K, Hacksell U. Peptides and peptidomimetics. In: Krogsgaard-Larsen P,
Liljefors T, Madsen U, editors. A textbook of drug design and development. Amsterdam:
Harwood Academic Publishers; 1996. p. 386-406.
Search WWH ::
Custom Search